COMMUNIQUÉS West-GlobeNewswire

Saniona AB: Saniona presents Tesomet Phase 2 data at the EASD Congress
12/09/2017
PRESS RELEASE September 12, 2017 Saniona, a leading biotech company in the field of ion channels, today announces that the promising data from its Phase 2a study with Tesomet in type 2 diabetes has been selected for two [...]
PCI Biotech: Initial clinical results from Phase I indicate that vaccination with fimaVACC enhances cellular immune responses
12/09/2017
Oslo (Norway), 12 September 2017 - PCI Biotech (OSE: PCIB), a cancer focused clinical-stage company developing innovative therapeutics that address significant unmet medical needs today announced that the first immune [...]
Sandoz proposed biosimilar rituximab accepted for review by the FDA
12/09/2017
Rituximab is indicated to treat blood cancers and immunological diseases such as rheumatoid arthritis[1] Sandoz believes the comprehensive data package submitted to the FDA for review confirms that our biosimilar [...]
Basilea announces distribution agreement with Cardiome to commercialize antibiotic Zevtera®/Mabelio® (ceftobiprole) in Europe and Israel
12/09/2017
Basel, Switzerland, September 12, 2017 - Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that Basilea Pharmaceutica International Ltd. (Basilea) has entered into a distribution agreement with Cardiome Pharma Corp [...]
TiGenix strengthens US operations with senior appointments
12/09/2017
PRESS RELEASE TiGenix strengthens US operations with senior appointments - Dr. Gregory Gordon appointed as Head of Medical Department (U.S.) - Annette Valles-Sukkar appointed as Associate Director, Clinical Project [...]
TiGenix consolide ses opérations aux États- Unis suite à la nomination de cadres supérieurs
12/09/2017
COMMUNIQUÉ DE PRESSE TiGenix consolide ses opérations aux États- Unis suite à la nomination de cadres supérieurs - Dr. Gregory Gordon sera à la tête du Département Médical (États-Unis). - Annette Valles-Sukkar occupera [...]
Ossur Hf : Transactions in relation to share buyback program
11/09/2017
Announcement from Össur hf. No. 66/2017 Reykjavík, 11 September 2017 On 15 August 2017, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2017. The purpose of the share buyback program is to [...]
Sanofi: Disclosure of trading in own shares
11/09/2017
Disclosure of trading in own shares This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients. The issuer of this announcement warrants that they are solely [...]
Sanofi : Déclaration des transactions sur actions propres
11/09/2017
Déclaration des transactions sur actions propres This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients. The issuer of this announcement warrants that they are [...]
Virbac: résultats du premier semestre en très légère progression
11/09/2017
Virbac : résultats du premier semestre en très légère progression Communiqué diffusé le 11 septembre 2017 CHIFFRES CONSOLIDÉS AU 30 JUIN en millions d'euros 2017 2016 Évolution 2017/2016 Chiffre d'affaires 437,5 430,0 + [...]
Virbac: slight increase in first half results
11/09/2017
Virbac: slight increase in first half results Press release issued on September 11, 2017 CONSOLIDATED DATA AS OF JUNE 30 th in million € 2017 2016 % change 2017/2016 Revenue from ordinary activities 437.5 430.0 +1.8% [...]
Virbac : Mise à disposition du rapport financier semestriel au 30 juin 2017
11/09/2017
Virbac Mise à disposition du rapport financier semestriel au 30 juin 2017 Communiqué diffusé le 11 septembre 2017 La société annonce avoir mis à la disposition du public et déposé auprès de l'Autorité des marchés [...]
Virbac: Availability of the first half-yearly financial report as of June 30, 2017
11/09/2017
Virbac Availability of the first half-yearly financial report as of June 30, 2017 Public release - September 11 th , 2017 Virbac announced today that the 2017 half-yearly financial report is now available and has been [...]
Biocartis Group NV: Results of the extraordinary shareholders' meeting held on 11 September 2017
11/09/2017
PRESS RELEASE: REGULATED INFORMATION 11 September 2017, 17:40 CEST Results of the extraordinary shareholders' meeting held on 11 September 2017 Mechelen, Belgium, 11 September 2017 - Biocartis Group NV (the 'Company' or [...]
Weifa ASA: Karo Pharma commences voluntary cash offer to acquire the entire issued share capital of Weifa
11/09/2017
Weifa ASA ("Weifa"; OSE: WEIFA) today announced that Karo Pharma AB (publ) ("Karo Pharma"), has commenced the voluntary cash offer (the "Offer") to acquire the entire issued share capital of Weifa for NOK 35 per share. [...]
Minerva Neurosciences Names Dr. Jay Saoud as Senior Vice President, Head of Research and Development
11/09/2017
WALTHAM, Mass., Sept. 11, 2017 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) [...]
EDAP Announces Filing of New 510(k) Application for Focal One® Device
11/09/2017
510(k) Includes New Clinical Data to Support EDAP's File LYON, France, September 11, 2017 -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced that the Company submitted a new 510(k [...]
Genedrive® HCV ID Kit received CE-IVD Certification
11/09/2017
11 September 2017 genedrive plc ("genedrive" or the "Company") Genedrive® HCV ID Kit received CE-IVD Certification Hepatitis C assay provides decentralised molecular testing to support the identification of patients [...]
Apricus Biosciences Announces $3.7 Million Private Placement Priced At-The-Market
11/09/2017
SAN DIEGO, Sept. 11, 2017 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that it has entered into [...]

Pages